APA (7th ed.) Citation

Isik, D., Alan, Ö., Akdağ, G., Yildirim, S., Kınıkoğlu, O., Altintas, Y. E., . . . Turan, N. (2024). Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older. Journal of Clinical Medicine, 13(20), 6263. https://doi.org/10.3390/jcm13206263

Chicago Style (17th ed.) Citation

Isik, Deniz, et al. "Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older." Journal of Clinical Medicine 13, no. 20 (2024): 6263. https://doi.org/10.3390/jcm13206263.

MLA (9th ed.) Citation

Isik, Deniz, et al. "Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older." Journal of Clinical Medicine, vol. 13, no. 20, 2024, p. 6263, https://doi.org/10.3390/jcm13206263.